Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-intensity statin vs statin + ezetimibe in polyvascular coronary and peripheral artery disease
KCT0008233Phase 4Recruiting
- Sponsor
- Chong Kun Dang
- Start
- Mar 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin, ezetimibe in coronary arteriosclerosis, arteriosclerosis obliterans, atherosclerosis, sponsored by Chong Kun Dang. Started Mar 2023; status: recruiting.
02
Drugs
ulinastatinezetimibe
03
Conditions
coronary arteriosclerosisarteriosclerosis obliteransatherosclerosis
Beyond the preview
Go deeper on KCT0008233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008233.